• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Market characteristics
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 - 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Consumables - Market size and forecast 2019-2024
o Instruments - Market size and forecast 2019-2024
o Market opportunity by Product
• Market Segmentation by End-user
o Market segments
o Comparison by End-user
o Pharmaceutical and biotechnology companies - Market size and forecast 2019-2024
o Academic and research institutes - Market size and forecast 2019-2024
o Clinical - Market size and forecast 2019-2024
o Others - Market size and forecast 2019-2024
o Market opportunity by End-user
• Customer Landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2019-2024
o Europe - Market size and forecast 2019-2024
o Asia - Market size and forecast 2019-2024
o ROW - Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
o Competitive scenario
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Agilent Technologies Inc.
o Bio-Rad Laboratories Inc.
o Danaher Corp.
o Eppendorf AG
o F. Hoffmann-La Roche Ltd.
o Harvard Bioscience Inc.
o Merck KGaA
o PerkinElmer Inc.
o QIAGEN NV
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Key Finding 9
• 9: Key Finding 10
• 10: Parent market
• 11: Market characteristics
• 12: Offerings of vendors included in the market definition
• 13: Market segments
• 14: Global - Market size and forecast 2019 - 2024 ($ million)
• 15: Global market: Year-over-year growth 2019 - 2024 (%)
• 16: Five forces analysis 2019 & 2024
• 17: Bargaining power of buyers
• 18: Bargaining power of suppliers
• 19: Threat of new entrants
• 20: Threat of substitutes
• 21: Threat of rivalry
• 22: Market condition - Five forces 2019
• 23: Product - Market share 2019-2024 (%)
• 24: Comparison by Product
• 25: Consumables - Market size and forecast 2019-2024 ($ million)
• 26: Consumables - Year-over-year growth 2019-2024 (%)
• 27: Instruments - Market size and forecast 2019-2024 ($ million)
• 28: Instruments - Year-over-year growth 2019-2024 (%)
• 29: Market opportunity by Product
• 30: End user - Market share 2019-2024 (%)
• 31: Comparison by End user
• 32: Pharmaceutical and biotechnology companies - Market size and forecast 2019-2024 ($ million)
• 33: Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2024 (%)
• 34: Academic and research institutes - Market size and forecast 2019-2024 ($ million)
• 35: Academic and research institutes - Year-over-year growth 2019-2024 (%)
• 36: Clinical - Market size and forecast 2019-2024 ($ million)
• 37: Clinical - Year-over-year growth 2019-2024 (%)
• 38: Others - Market size and forecast 2019-2024 ($ million)
• 39: Others - Year-over-year growth 2019-2024 (%)
• 40: Market opportunity by End user
• 41: Customer landscape
• 42: Market share by geography 2019-2024 (%)
• 43: Geographic comparison
• 44: North America - Market size and forecast 2019-2024 ($ million)
• 45: North America - Year-over-year growth 2019-2024 (%)
• 46: Europe - Market size and forecast 2019-2024 ($ million)
• 47: Europe - Year-over-year growth 2019-2024 (%)
• 48: Asia - Market size and forecast 2019-2024 ($ million)
• 49: Asia - Year-over-year growth 2019-2024 (%)
• 50: ROW - Market size and forecast 2019-2024 ($ million)
• 51: ROW - Year-over-year growth 2019-2024 (%)
• 52: Key leading countries
• 53: Market opportunity by geography ($ million)
• 54: Impact of drivers and challenges
• 55: Vendor landscape
• 56: Landscape disruption
• 57: Industry risks
• 58: Vendors covered
• 59: Market positioning of vendors
• 60: Agilent Technologies Inc. - Overview
• 61: Agilent Technologies Inc. - Business segments
• 62: Agilent Technologies Inc. - Key offerings
• 63: Agilent Technologies Inc. - Key customers
• 64: Agilent Technologies Inc. - Segment focus
• 65: Bio-Rad Laboratories Inc. - Overview
• 66: Bio-Rad Laboratories Inc. - Business segments
• 67: Bio-Rad Laboratories Inc. - Key offerings
• 68: Bio-Rad Laboratories Inc. - Key customers
• 69: Bio-Rad Laboratories Inc. - Segment focus
• 70: Danaher Corp. - Overview
• 71: Danaher Corp. - Business segments
• 72: Danaher Corp. - Key offerings
• 73: Danaher Corp. - Key customers
• 74: Danaher Corp. - Segment focus
• 75: Eppendorf AG - Overview
• 76: Eppendorf AG - Business segments
• 77: Eppendorf AG - Key offerings
• 78: Eppendorf AG - Key customers
• 79: Eppendorf AG - Segment focus
• 80: F. Hoffmann-La Roche Ltd. - Overview
• 81: F. Hoffmann-La Roche Ltd. - Business segments
• 82: F. Hoffmann-La Roche Ltd. - Key offerings
• 83: F. Hoffmann-La Roche Ltd. - Key customers
• 84: F. Hoffmann-La Roche Ltd. - Segment focus
• 85: Harvard Bioscience Inc. - Overview
• 86: Harvard Bioscience Inc. - Business segments
• 87: Harvard Bioscience Inc. - Key offerings
• 88: Harvard Bioscience Inc. - Key customers
• 89: Harvard Bioscience Inc. - Segment focus
• 90: Merck KGaA - Overview
• 91: Merck KGaA - Business segments
• 92: Merck KGaA - Key offerings
• 93: Merck KGaA - Key customers
• 94: Merck KGaA - Segment focus
• 95: PerkinElmer Inc. - Overview
• 96: PerkinElmer Inc. - Business segments
• 97: PerkinElmer Inc. - Key offerings
• 98: PerkinElmer Inc. - Key customers
• 99: PerkinElmer Inc. - Segment focus
• 100: QIAGEN NV - Overview
• 101: QIAGEN NV - Business segments
• 102: QIAGEN NV - Key offerings
• 103: QIAGEN NV - Key customers
• 104: QIAGEN NV - Segment focus
• 105: Thermo Fisher Scientific Inc. - Overview
• 106: Thermo Fisher Scientific Inc. - Business segments
• 107: Thermo Fisher Scientific Inc. - Key offerings
• 108: Thermo Fisher Scientific Inc. - Key customers
• 109: Thermo Fisher Scientific Inc. - Segment focus
• 110: Currency conversion rates for US$
• 111: Research Methodology
• 112: Validation techniques employed for market sizing
• 113: Information sources
• 114: List of abbreviations

Companies Mentioned
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• Danaher Corp.
• Eppendorf AG
• F. Hoffmann-La Roche Ltd.
• Harvard Bioscience Inc.
• Merck KGaA
• PerkinElmer Inc.
• QIAGEN NV
• Thermo Fisher Scientific Inc.